Chronic obstructive pulmonary disease is one of the most common chronic lung diseases today and is a serious health, economic and social problem. It is characterized by a progressively worsening airway obstruction leading to respiratory insufficiency, even to death. Co-morbid mental disorders such as depression and anxiety are very common in patients with this condition and are associated with increased morbidity. Although they generally impair quality of life, they are rarely examined in the context of the clinical treatment of such patients. Studies indicate that the prevalence of clinically significant depressive symptoms and anxiety is around 50%. This study deals with the prevalence of depression in patients with chronic obstructive pulmonary disease, and gives an overview of the instruments used for assessing the extent of such depression. S Ú h R NChronická obštrukčná choroba pľúc patrí dnes medzi najčastejšie chronické pľúcne ochorenia a predstavuje závažný zdravotnícky, ekonomický a spoločenský problém ľudskej populácie. Jej základným znakom je progresívne sa zhoršujúca porucha priechodnosti dýchacích ciest, ktorá vedie k respiračnej insuficiencii, až k smrti. Komorbídne psychické poruchy ako depresia a úzkosť sa vyskytujú často a sú spájané so zvýšenou morbiditou. Celkovo zhoršujú kvalitu života, pričom nie sú plne preskúmané v klinickej liečbe pacientov. Existujúce štúdie poukazujú na výskyt klinicky významných príznakov depresie a úzkosti vo výške okolo 50 %. Nasledujúca práca sa zaoberá výskytom depresie u pacientov s chronickou obštrukčnou chorobou pľúc, ako aj prehľadom dotazníkov, ktorými sa hodnotí depresia v populácii.

No abstract

The aim of the study was to assess the quality life of patients with psoriasis treated with biologics, and to analyze the various factors that determine it. Methods: The cross-sectional study was realized with 117 patients at the Centre for Biologic Therapy in Slovakia. The factors analyzed were: Dermatology Life Quality Index (DLQI), The Brief Illness Perception Questionnaire (BIPQ), General Anxiety Disorder-7 (GAD-7), Psoriasis Area Severity Index (PASI), localization of skin changes, duration of the disease, length of use of biologics, BMI. Results: Mean score of DLQI was 9.03 (SD = 6.59, range = 2-23). DLQI significantly correlates with PASI (r = 0.347), length of use of biologics (r =-0.286), illness perception (r = 0.557) and anxiety (r = 0.338). Hierarchical regression analysis showed that PASI (β = 0.252) and illness perception (β = 2.209) were significant predictors of a patient's quality life. Conclusions: The findings of study indicate that the quality life of psoriatic patients treated with biologics is determined by the disease severity and illness perception. Therefore it is very important to include a psychosocial dimension (assessment, effective intervention) in the care of these patients.

Prešovská univerzita v Prešove, Fakulta zdravotníckych odborov, Katedra ošetrovateľstva 2 Dentálna klinika, Humenné Článok poskytuje kompletný prehľad o problematike a liečbe alopécie u mladých žien. Na základe detailnej analýzy prípadu sme zistili, že uvádzané ochorenie závisí od účinnosti terapie u žien. Nezastupiteľné postavenie v úspešnej liečbe alopécie nemá len široké spektrum terapeutických postupov, ale aj prístup lekára k pacientke, psychologická starostlivosť a dostatočná podpora od príbuzných a blízkych priateľov. Kľúčové slová: alopécia, vyšetrenia, dopad ochorenia, terapia. The problems of alopecia in young women The article is providing a complete owerview on the issues and treatment of alopecia in young women. On the basis of detailed analysis of the case we have found that the disease affects on teraphy in women. Irreplaceable role in the successful treatment of alopecia is not only a wide range of therapeutic procedures, as well as access to patient medical, psychological care and adequate support from relatives and close friends.

No abstract